Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment.
Förnvik D, Aaltonen KE, Chen Y, George AM, Brueffer C, Rigo R, Loman N, Saal LH, Rydén L. Förnvik D, et al. Among authors: rigo r. Breast Cancer Res Treat. 2019 Sep;177(2):447-455. doi: 10.1007/s10549-019-05326-5. Epub 2019 Jun 24. Breast Cancer Res Treat. 2019. PMID: 31236809 Free PMC article.
Synthesis and estrogenic activity of BODIPY-labeled estradiol conjugates.
Peřina M, Börzsei R, Henrietta Ágoston, Hlogyik T, Poór M, Rigó R, Özvegy-Laczka C, Batta G, Hetényi C, Vojáčková V, Jorda R, Mernyák E. Peřina M, et al. Among authors: rigo r. Eur J Pharm Sci. 2024 Aug 1;199:106813. doi: 10.1016/j.ejps.2024.106813. Epub 2024 May 24. Eur J Pharm Sci. 2024. PMID: 38797442 Free article.
In-cell NMR suggests that DNA i-motif levels are strongly depleted in living human cells.
Víšková P, Ištvánková E, Ryneš J, Džatko Š, Loja T, Živković ML, Rigo R, El-Khoury R, Serrano-Chacón I, Damha MJ, González C, Mergny JL, Foldynová-Trantírková S, Trantírek L. Víšková P, et al. Among authors: rigo r. Nat Commun. 2024 Mar 5;15(1):1992. doi: 10.1038/s41467-024-46221-y. Nat Commun. 2024. PMID: 38443388 Free PMC article.
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
Podzamczer D, Imaz A, Lopez-Lirola A, Knobel H, Masiá M, Fanciulli C, Hernández C, Lagarde M, Gutierrez A, Curran A, Morano L, Montero-Alonso M, Troya J, Rigo R, Casadellà M, Navarro-Alcaraz A, Ardila F, Parera M, Bernal E, Echeverria P, Estrada V, Hidalgo-Tenorio C, Macias J, Prieto P, Portilla J, Valencia E, Vivancos MJ, Rivero A. Podzamczer D, et al. Among authors: rigo r. J Antimicrob Chemother. 2023 Nov 6;78(11):2696-2701. doi: 10.1093/jac/dkad285. J Antimicrob Chemother. 2023. PMID: 37725999 Clinical Trial.
77 results